Skip to main content
Top
Published in: The journal of nutrition, health & aging 9/2018

01-11-2018

Comparing SARC-F with SARC-CalF to Screen Sarcopenia in Community Living Older Adults

Authors: Gülistan Bahat, M. M. Oren, O. Yilmaz, C. Kiliç, K. Aydin, M. A. Karan

Published in: The journal of nutrition, health & aging | Issue 9/2018

Login to get access

Abstract

Objective

To compare the diagnostic value of the SARC-F combined with calf circumference (SARC-CalF) with the standard SARC-F to screen sarcopenia in community-dwelling older adults.

Design

Cross-sectional, diagnostic accuracy study.

Setting

Geriatric outpatient clinic of a university hospital.

Participants

Older adults >= 65 years.

Measurements

Muscle mass (bioimpedance analysis device), muscle strength (hand grip strength-Jamar hydraulic hand dynamometer), and physical performance (usual gait speed). Four currently used diagnostic criteria [European Working Group on Sarcopenia in Older People (EWGSOP), Foundation for the National Institutes of Health (FNIH), International Working Group on Sarcopenia (IWGS), and Society on Sarcopenia Cachexia and Wasting Disorders (SCWD) criteria] were applied. SARC-CalF was performed by using two different calf circumference threshold: standard cut-off 31 cm (SARC-CalF-31) and national cut-off 33 cm (SARC-CalF-33). The sensitivity/specificity analyses of the SARC-CalF and SARC-F tools were run. We used the receiver operating characteristics curves and the area under the receiver operating characteristics curves (AUC) to compare the diagnostic accuracy to identify sarcopenia.

Results

We included 207 subjects; 67 male and 140 female with a mean age of 74.6±6.7 years. The prevalence of sarcopenia ranged from 1.9% to 9.2%. The sensitivity of SARC-F was between 25% (EWGSOP) and 50% (IWGS); specificity was about 82%. For SARC-CalF-31 and SARC-CalF-33 sensitivity was in general similar - between 25-50%-which pointed out that SARC-CalF was not superior to SARC-F for sensitivity in this sample. Corresponding specificities for SARCCalF-31 and SARC-CalF-33 were higher than SARC-F and were between 90-98%. Additionally, the AUC values, which indicates the diagnostic accuracy of a screening test, were in general higher for SARC-CalF-33 than the SARC-F and SARC-CalF-31.

Conclusions

We reported that addition of calf circumference item to SARC-F tool improved the specificity and diagnostic accuracy of SARC-F but it did not improve the sensitivity in a community-dwelling Turkish older adult population sample that had low prevalence of sarcopenia. The performance of SARC-CalF tool to screen sarcopenia is to be studied in different populations and living settings.
Literature
1.
go back to reference Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing 2014; 43: 748–59.PubMedPubMedCentral Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing 2014; 43: 748–59.PubMedPubMedCentral
2.
go back to reference Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014; 15: 630–34.CrossRefPubMed Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014; 15: 630–34.CrossRefPubMed
3.
go back to reference Parra-Rodríguez L, Szlejf C, García-González AI et al. Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults. J Am Med Dir Assoc 2016; 17: 1142–1146.CrossRefPubMed Parra-Rodríguez L, Szlejf C, García-González AI et al. Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults. J Am Med Dir Assoc 2016; 17: 1142–1146.CrossRefPubMed
4.
go back to reference Beaudart C, Locquet M, Bornheim S et al. French translation and validation of the sarcopenia screening tool SARC-F. Eur Geriatr Med 2018;9.1:29–37.CrossRef Beaudart C, Locquet M, Bornheim S et al. French translation and validation of the sarcopenia screening tool SARC-F. Eur Geriatr Med 2018;9.1:29–37.CrossRef
5.
go back to reference Yang M, Hu X, Xie L et al. Screening Sarcopenia in Community-Dwelling Older Adults: SARC-F vs SARC-F Combined With Calf Circumference (SARC-CalF). J Am Med Dir Assoc 2018;19:277.CrossRefPubMed Yang M, Hu X, Xie L et al. Screening Sarcopenia in Community-Dwelling Older Adults: SARC-F vs SARC-F Combined With Calf Circumference (SARC-CalF). J Am Med Dir Assoc 2018;19:277.CrossRefPubMed
6.
go back to reference Barbosa-Silva TG, Menezes AM, Bielemann RM et al. Enhancing SARC-F: Improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc 2016;17:1136–141.CrossRefPubMed Barbosa-Silva TG, Menezes AM, Bielemann RM et al. Enhancing SARC-F: Improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc 2016;17:1136–141.CrossRefPubMed
7.
go back to reference Bahat G., Yilmaz O., Kiliç C., Oren M.M. et al. Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging in press Bahat G., Yilmaz O., Kiliç C., Oren M.M. et al. Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging in press
8.
go back to reference Fess EE (1992). Grip strength. In: Casanova JS(ed) Clinical assessment recommendations, American Society of Hand Therapists; 2nd edn. Chicago. pp 41–45. Fess EE (1992). Grip strength. In: Casanova JS(ed) Clinical assessment recommendations, American Society of Hand Therapists; 2nd edn. Chicago. pp 41–45.
9.
go back to reference Massy-Westropp NM, Gill TK, Taylor AW et al. Hand grip strength: age and gender stratified normative data in a population-based study. BMC Res Notes 2011; 14:127.CrossRef Massy-Westropp NM, Gill TK, Taylor AW et al. Hand grip strength: age and gender stratified normative data in a population-based study. BMC Res Notes 2011; 14:127.CrossRef
10.
go back to reference Bahat G, Tufan A, Tufan F et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 2016; 35:1557–563.CrossRefPubMed Bahat G, Tufan A, Tufan F et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 2016; 35:1557–563.CrossRefPubMed
11.
go back to reference Studenski SA, Peters KW, Alley DE et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biol Sci Med Sci 2014; 69: 547–58.CrossRef Studenski SA, Peters KW, Alley DE et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biol Sci Med Sci 2014; 69: 547–58.CrossRef
12.
go back to reference Malmstrom TK, Morley JE. SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013; 14: 531–532.CrossRefPubMed Malmstrom TK, Morley JE. SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013; 14: 531–532.CrossRefPubMed
13.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412–23.CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412–23.CrossRefPubMedPubMedCentral
14.
go back to reference Fielding RA, Vellas B, Evans WJ et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249–256.CrossRefPubMed Fielding RA, Vellas B, Evans WJ et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249–256.CrossRefPubMed
15.
16.
go back to reference Katz S, Ford AB, Moskowitz RW, Jackson BA et al. Studies of illness in the aged. The Index of Adl: a standardized measure of biological and psychosocial function. JAMA 1963; 185:914–9.CrossRefPubMed Katz S, Ford AB, Moskowitz RW, Jackson BA et al. Studies of illness in the aged. The Index of Adl: a standardized measure of biological and psychosocial function. JAMA 1963; 185:914–9.CrossRefPubMed
17.
go back to reference MP, Brody EM. Assessment of older people: self-management. Gerontologist 1969; 9:179–86.CrossRef MP, Brody EM. Assessment of older people: self-management. Gerontologist 1969; 9:179–86.CrossRef
18.
go back to reference Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33:337–43.CrossRefPubMed Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33:337–43.CrossRefPubMed
19.
go back to reference Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996; 54:59–65.CrossRef Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996; 54:59–65.CrossRef
20.
go back to reference Wu TY, Liaw CK, Chen FC et al. Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality. J Am Med Dir Assoc 2016;17: 1129–135.CrossRefPubMed Wu TY, Liaw CK, Chen FC et al. Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality. J Am Med Dir Assoc 2016;17: 1129–135.CrossRefPubMed
21.
go back to reference Malmstrom TK, Miller DK, Simonsick EM et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7: 28–36.CrossRefPubMed Malmstrom TK, Miller DK, Simonsick EM et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7: 28–36.CrossRefPubMed
22.
go back to reference Urzi F, Šimunič B, Buzan E. Basis for Sarcopenia Screening With the SARC-CalF in Nursing Homes. J Am Med Dir Assoc 2017; 18:991.e5–991–10.CrossRef Urzi F, Šimunič B, Buzan E. Basis for Sarcopenia Screening With the SARC-CalF in Nursing Homes. J Am Med Dir Assoc 2017; 18:991.e5–991–10.CrossRef
Metadata
Title
Comparing SARC-F with SARC-CalF to Screen Sarcopenia in Community Living Older Adults
Authors
Gülistan Bahat
M. M. Oren
O. Yilmaz
C. Kiliç
K. Aydin
M. A. Karan
Publication date
01-11-2018
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 9/2018
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-018-1072-y

Other articles of this Issue 9/2018

The journal of nutrition, health & aging 9/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.